Agarwal Arjun sold ORKA
October 12, 2026 · Form 4 insider transaction
Agarwal Arjun sold 1,958 shares of Oruka Therapeutics, Inc. at $81.86 per share, a transaction worth $160.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,958
Price
$81.86
Total value
$160.3K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 12, 2026
Filing dateOctober 13, 2026
Shares owned after14,419
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.61 to $82.50, inclusive.